Similar articles

• [Clavulanic acid-shielded amoxicillin in the treatment of acute and chronic infective diseases of the pulmonary system].

  Micillo E, Dericoloso A, Tranchese D, Cione P. Micillo E, et al. Arch Monaldi Mal Torace. 1987 Nov-Dec;42(6):535-49. Arch Monaldi Mal Torace. 1987. PMID: 3334116 Clinical Trial. Italian. No abstract available.
• [Therapy of infective respiratory diseases with a shielded beta-lactam antibiotic (amoxicillin and clavulanic acid)].

  Palermo B, Rizza S, Pistorio MP, Crimi N, Maccarrone C, Mistretta A. Palermo B, et al. Arch Monaldi Mal Torace. 1987 Nov-Dec;42(6):519-33. Arch Monaldi Mal Torace. 1987. PMID: 3334115 Clinical Trial. Italian. No abstract available.
• [Usefulness of an amoxicillin/clavulanic-acid combination in respiratory tract infection: bacterial resistance and antibiotic therapy].

  Caramia M, Taddei G, Nobilini A. Caramia M, et al. Minerva Pediatr. 1990 Jan-Feb;42(1-2):29-34. Minerva Pediatr. 1990. PMID: 2186263 Review. Italian.
• Treatment of respiratory tract infections with a combination of amoxycillin and clavulanic acid.

  Karachalios GN. Karachalios GN. Int J Clin Pharmacol Ther Toxicol. 1985 Dec;23(12):647-9. Int J Clin Pharmacol Ther Toxicol. 1985. PMID: 4093205
• [Augmentin--current and prospective therapeutic indications].

  Mihălţan F. Mihălţan F. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1988 Jul-Sep;37(3):203-10. Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol. 1988. PMID: 2855664 Review. Romanian. No abstract available.